Investigator Initiated Studies
Investigator Initiated Studies Solution
Funding investigator initiated research is an investment, and maximizing return should be a key consideration whether in the form of publications, useful data or stronger community relationships. Many investigators lack operational resources to effectively manage a study, reducing the likelihood that the project is successful. For those investigators that have access to resources, Clinipace can offer the specialized support you need.
How Clinipace's TEMPO Can Help
Through TEMPO, our integrated clinical research software platform, Clinipace can balance the needs of sponsors and investigators by providing the complete technology and support infrastructure to collect and manage study data and associated business processes. Our turn-key IIR solution includes:
- Clinical research solution hosted in top-tier data center
- Study set-up and support
- Data collection and trial management tools
- Reporting
- Logistics/Workflow Management
Benefit to the Academic Medical Center (AMC)
With Clinipace, study sponsors simply provide investigator access to the TEMPO platform and Clinipace manages the rest. As the sponsor, you maintain access to progress and milestone reports based on your internal guidelines. From study to study, you will know that study results will meet your quality standards and conform to the changing regulatory environment for IIR.
Benefit to the Sponsor
Study sponsors can provide an affordable, standardized clinical research management platform that empowers investigators to meet milestones while ensuring data quality and study integrity.
- Improve study quality, yielding more publishable data
- Enhance ability to track adverse events and monitor study progress
- Efficiently manage and track investigator payments
- Ready-access to review study data (if applicable)
Benefit to the Medical Liaisons (MSLs)
TEMPO provides MSLs the power to facilitate research funding, plus offer value-added resources to help manage the study. In the process, the MSL will enjoy unprecedented management oversight capabilities via the TEMPO web-based research platform to ensure projects are completed in accordance with study objectives and time frames.
- Improved ability to monitor patient accrual and other key study milestones
- More effective and timely troubleshooting of study inhibitors
- Value-added services deepen relationships with opinion-leaders
- Enhanced communication with investigators and other stakeholders
- Quickly realize collaboration potential between sponsors and opinion-leaders
